Empaveli 1080 MG

Ended Awarded

Contract number
36C24525N0342
Awardee
Awarding agency
Obligated
$26,219

Award facts

Contract value 100% obligated
$26,218.96 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Pittsburgh, PA 15275, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award was issued by the Veterans Integrated Service Network 5 (VISN 5), a division of the U.S. Department of Veterans Affairs (VA), to APL Sales I LLC, a subsidiary of Apellis Pharmaceuticals, Inc. The $26,218.96 firm fixed-price delivery order is for the supply of EMPAVELI 1080 MG, a pharmaceutical product used to treat paroxysmal nocturnal hemoglobinuria, a rare blood disorder. The contract is placed under the VA's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) and has a period of performance through January 28, 2025. This award is not associated with any set-aside designation. APL Sales I LLC, a for-profit limited liability company, has an established history of providing specialized pharmaceutical products to the VA, particularly within the VISN 5 region covering western Pennsylvania and parts of West Virginia. The contract is part of the VA's efforts to ensure consistent access to critical medications for veterans' healthcare needs.

Quick answers

Who was awarded contract 36C24525N0342?

36C24525N0342 was awarded to APL Sales I LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on January 24, 2025.

How much is contract 36C24525N0342 worth?

The government has obligated $26,219 on 36C24525N0342.

Is contract 36C24525N0342 an order under another contract?

Yes. 36C24525N0342 is a delivery order under 36F79722D0039, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24525N0342 competed?

The extent of competition for 36C24525N0342 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award